BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

BIO-key reported Q2 revenue of $1.9 million, up 13% year-over-year, while narrowing its net loss by 51% to $577,000 driven by a 14-point improvement in gross margin to 87%. Management maintained a positive outlook for the second half of 2026, targeting revenue growth and profitability as a delayed $0.8M hardware order shifts into the period.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.